Singapore, Singapore

Cedric Callens

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: The Institute of Cancer Research: Royal Cancer Hospital. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cedric Callens. Retrieved from https://idiyas.com/inventor/cedric-callens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Cedric Callens: Revolutionizing Technology in Singapore

Introduction: Cedric Callens is a visionary inventor based in Singapore, SG, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Cedric Callens holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Cedric Callens has worked with leading tech companies and research institutions to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Cedric Callens has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Cedric Callens continues to be a driving force in the world of technology, inspiring the next generation of inventors and pushing the boundaries of what is possible in the realm of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…